Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2A type 1-H (H2AC12) is a member of the H2A core histone protein family, essential for the packaging of DNA into nucleosomes and formation of chromatin in eukaryotic cells[1][3]. Like other core histones, it contributes to the organization of chromatin, regulates DNA accessibility, and impacts gene expression through nucleosome assembly. The H2A family is highly diverse, containing multiple variants that influence chromatin dynamics and DNA-related processes such as repair, transcription, and cell cycle regulation[1][3]. Some H2A family members, including canonical forms like H2A type 1-H, have also been implicated in cellular antimicrobial responses and the DNA damage response. There is no evidence that H2AC12 functions as a direct therapeutic target (receptor, enzyme, transporter, etc.), and it does not currently represent a specific drug target, predictive biomarker, or clinical safety concern[1][3]. Alterations or mutations in histone genes in general can play a role in genome instability and are associated with various diseases including cancer, but not in an isoform-specific manner.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2A type 1-H (H2AC12).